UNC Chapel Hill Health System is a clinical research site located in Chapel Hill, North Carolina, United States 27514.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
UNC Chapel Hill Health System has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: BRCA1 Mutation, BRCA2 Mutation.
Sponsors: Duke University.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UNC Chapel Hill Health System has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UNC Chapel Hill Health System has 1 clinical trials on record, with 1 currently active. Their work covers BRCA1 Mutation, BRCA2 Mutation.
UNC Chapel Hill Health System has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.